Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.4 HKD | 0.00% | +3.45% | -19.76% |
04-25 | Simcere Pharmaceutical’ Profit Down 23% in 2023 | MT |
04-10 | Simcere Pharmaceutical's Cancer Drug Gets Fast Track Designation From US FDA | MT |
Evolution of the average Target Price on Simcere Pharmaceutical Group Limited
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Simcere Pharmaceutical Group Limited
UBS | |
Nomura |
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- 2096 Stock
- Consensus Simcere Pharmaceutical Group Limited